MWNA
ACER

Marshall Wace North America’s Acer Therapeutics Inc ACER Stock Holding History

Marshall Wace North America’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-39,872
Closed -$1.23M – 1688
2018
Q3 		$1.23M Hold
39,872
– – 0.01% 577
2018
Q2 		$861K Buy
39,872
+19,800
+99% +$376K ﹤0.01% 967
2018
Q1 		$379K Buy
+20,072
New +$368K ﹤0.01% 1222

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace North America's ACER Position: Q4 2018 in Review

Marshall Wace North America sold out of Acer Therapeutics Inc (ACER) in Q4 2018, closing a stake of 39,872 shares — an estimated $1.23M sold.

Marshall Wace North America first reported a position in ACER in Q1 2018 and held it in 3 quarters. The position peaked at $1.23M in Q3 2018. 28 funds tracked by Wall St. Rank hold ACER as of Q4 2018.

  • Marshall Wace North America reported no remaining Acer Therapeutics Inc position as of Q4 2018 after selling out during the quarter.
  • Marshall Wace North America sold 39,872 Acer Therapeutics Inc shares in Q4 2018, an estimated $1.23M.
  • Marshall Wace North America first reported a position in Acer Therapeutics Inc in Q1 2018 and held it in 3 quarters.
  • Marshall Wace North America's Acer Therapeutics Inc position peaked at $1.23M in Q3 2018.
  • 28 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2018.

Based on Marshall Wace North America's 13F filing for Q4 2018, filed 14 Feb 2019.